A team of researchers at various European universities coordinated by Professor Dr Erik W. Baars has collected available information on the use of CAM strategies regarding the use and prescription of alternatives to antibiotics in France, Germany, the Netherlands, Switzerland and the United Kingdom. The working group has further focused on the development of an evidence and expertise based decision-making tool for (conventional) doctors and the implementation of this tool in the European countries.
Participants of JPIAMR working group:
- Erik Baars MD PhD, epidemiologist. Professor of Anthroposophic Healthcare at the University of Applied Sciences, Leiden; Senior researcher at Louis Bolk Institute, Driebergen, the Netherlands.
- Thomas Breitkreuz MD. President of IVAA. Board member and spokesperson of Hufelandgesellschaft.
- Roman Huber MD, Professor of Internal Medicine and Gastro-enterology. Center for Complementary Medicine of the Medical Center – University of Freiburg.
- Josef Hummelsberger MD, International Society for Chinese Medicine (SMS), Germany, Visiting Professor Chengdu TCM University, China.
- † George Lewith MD PhD. Professor of Health Research at the University of Southampton, UK.
- David Martin MD PhD. Director of the Institute of Integrative Medicine and Chair of Medical Theory, Integrative and Anthroposophic Medicine at the University of Witten-Herdecke; Professor of Pediatrics at Tübingen University, Senior Consultant for General Paediatrics, Paediatric Endocrinology, Diabetology, Oncology at the Filderklinik, Germany.
- Harald Matthes MD PhD. Professor of Anthroposophic Medicine & Integrative Medicine, Charité University, Berlin, Germany. Medical director Havelhöhe clinic, Berlin, Germany.
- Michael Teut MD. Clinical trial investigator at the Institute for Social Medicine, Epidemiology and Health Economics, Charité University, Berlin, Germany.
- Madan Thangavelu PhD, Trustee of the Research Council for Complementary Medicine, UK. Genome Biologist & Erstwhile Research Fellow, Medical Research Council Laboratory of Molecular Biology and MRC-Cancer Cell Unit, Cambridge, UK.
- Jan Vagedes MD, MA, Pediatrician, Scientific Director of the ARCIM Institute, Scientific Member of the University of Tübingen, Germany.
- Esther Van der Werf-Kok PhD, Epidemiologist. Lecturer in Primary Care Infectious Disease Epidemiology. Centre for Academic Primary Care, Bristol Medical School, University of Bristol, UK.
- Willem van Leeuwen PhD, microbiologist. Professor of Innovative Molecular Diagnostics, University of Applied Sciences, Leiden, The Netherlands.
- Klaus von Ammon MD. Senior researcher at the University of Berne, Institute for Complementary Medicine (IKOM), Switzerland.
- Merlin Willcox, General Medical Practitioner and Academic Clinical Lecturer at the Department of Primary Care and Population Sciences at the University of Southampton, UK.
JPIAMR, the Joint Programming Initiative on Antimicrobial Resistance, was formed 2011 by 15 European Countries with the support of the European Commission and now comprise 26 countries globally. It aims to integrate relevant scientific fields across national borders and to create a common Strategic Research Agenda with a shared common vision where the best resources and capabilities are coordinated. It provides the forum and platform for initiating and coordinating joint actions jointly with Stakeholders beyond issuing joint calls.
JPIAMR support new evidence and innovations that reduce the burden of antimicrobial resistance through coordinated global collaborative research in Europe and around the world. Also aiming to undertake further research to better understand how resistance develops and spreads in the environment. And to develop diagnostic tools and better surveillance methods as well as validating smarter strategies for using antibiotics in healthcare and agriculture.
JPIAMR is funding € 65 M of basic and exploratory research on new antibiotics, stewardship of existing antibiotics, and studies and control of the spread of antibiotic resistance between humans, animals, and the environment in a One Health perspective.
More information available at: jpiamr.eu
EUROCAM is a foundation uniting European organisations representing CAM patients and trained CAM health professionals, including medical doctors, veterinarians and other practitioners. The aim of EUROCAM is to promote the contribution of CAM – Complementary and Alternative Medicine – to better health in Europe.
EUROCAM covers a broad spectrum of CAM modalities, including acupuncture, ayurveda, anthroposophic medicine, herbal medicine, homeopathic medicine, naturopathic or traditional European medicine, osteopathy and traditional Chinese medicine.
The objective of EUROCAM is to promote and facilitate CAM’s role in maintaining citizens’ health, highlight the health promotion and illness prevention aspects of CAM for EU public health policy and programmes, to advance the accessibility, affordability and availability of CAM, and generally promote CAM at European level.
More information available at: cam-europe.eu